| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |